Company Propanc Health Group Corp Other OTC
Equities
US74345C1027
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 07-10-14 | |
Julian Kenyon
FOU | Founder | 77 | 07-10-14 |
Klaus Kutz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 07-10-14 | |
Julian Kenyon
FOU | Founder | 77 | 07-10-14 |
Josef Zelinger
BRD | Director/Board Member | 74 | 20-12-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1 | 0 | 0 | 97.69 % |
Stock B | 1 | 52,144,948 | 51,426,241 ( 98.62 %) | 0 | |
Stock C | 0 | 500,000 | 0 | 500,000 ( 100.00 %) |
Company contact information
Propanc Biopharma, Inc.
6 Butler Street Suite 302
3124, Camberwell
+61 3 9882 0780
http://www.propanc.comSector
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- PPCB Stock
- Stock
- Company Propanc Health Group Corp